Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Not applicableNot Yet RecruitingNCT06718647
What this trial is testing

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic Disease
Monica Boitano 150
Testing effectiveness (Phase 2)Study completedNCT02528643
What this trial is testing

Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Astellas Pharma Global Development, Inc. 165
Testing effectiveness (Phase 2)Looking for participantsNCT06126731
What this trial is testing

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Institute of Cancer Research, United Kingdom 39
Testing effectiveness (Phase 2)Ended earlyNCT02685267
What this trial is testing

Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Prostate Cancer Clinical Trials Consortium 9
Testing effectiveness (Phase 2)Ended earlyNCT02605863
What this trial is testing

Enzalutamide for Bladder Cancer Chemoprevention

Who this might be right for
Bladder Cancer
University of Rochester 1
Testing effectiveness (Phase 2)WithdrawnNCT01663415
What this trial is testing

Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Global Development, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT04076059
What this trial is testing

An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone Sensitive Prostate Cancer
Astellas (Beijing) Pharmaceutical R&D Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT03148795
What this trial is testing

Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 128
Not applicableStudy completedNCT02228265
What this trial is testing

Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
OHSU Knight Cancer Institute 41
Not applicableWithdrawnNCT03325127
What this trial is testing

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer
Testing effectiveness (Phase 2)Study completedNCT03480646
What this trial is testing

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Constellation Pharmaceuticals 175
Early research (Phase 1)Study completedNCT01902251
What this trial is testing

Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients

Who this might be right for
Prostate CancerPharmacokinetics of Enzalutamide
Astellas Pharma Europe B.V. 27
Testing effectiveness (Phase 2)UnknownNCT03700099
What this trial is testing

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Instituto do Cancer do Estado de São Paulo 30
Testing effectiveness (Phase 2)Looking for participantsNCT05422911
What this trial is testing

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Who this might be right for
Metastatic CancerNeoplasm, ProstateCastrate-sensitive+1 more
Sun Pharmaceutical Industries Limited 192
Testing effectiveness (Phase 2)Active Not RecruitingNCT03809000
What this trial is testing

Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Who this might be right for
Prostate Cancer
RTOG Foundation, Inc. 188
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Early research (Phase 1)Study completedNCT02204072
What this trial is testing

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Boehringer Ingelheim 120
Testing effectiveness (Phase 2)Study completedNCT01650194
What this trial is testing

Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 60
Early research (Phase 1)Ended earlyNCT04033328
What this trial is testing

Study of ORIC-101 in Combination With Enzalutamide

Who this might be right for
Prostatic Neoplasms
ORIC Pharmaceuticals 41
Next Page